PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases Sensorion announces positive data from the first cohort of the Audiogene Phase 1/2 Gene Therapy Clinical Trial, showing safety and hearing improvement in toddlers. Second cohort recruitment near completion Gene Therapy Clinical Trial Sensorion Audiogene Hearing Improvement
PRESS RELEASE published on 07/01/2025 at 07:30, 1 year 3 months ago Informations privilégiées / Autres communiqués Sensorion annonce des données préliminaires positives de la première cohorte de l'essai clinique de Phase 1/2 de thérapie génique Audiogene évaluant le SENS-501 pour traiter une forme spécifique de surdité congénitale Sécurité Thérapie Génique Sensorion Surdité Audiogene
BRIEF published on 05/13/2025 at 07:35, 1 year 5 months ago Sensorion Announces Approval of Shareholders’ Meeting Resolutions Biotechnology Gene Therapy Shareholder Resolutions Sensorion Hearing Loss Therapy
BRIEF published on 05/13/2025 at 07:35, 1 year 5 months ago Sensorion annonce l'approbation des résolutions de l'assemblée générale des actionnaires Biotechnologie Thérapie Génique Sensorion Résolutions Des Actionnaires Thérapie De La Perte Auditive
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion announces successful adoption of all resolutions at Combined General Meeting. Results available on company's website Biotechnology Resolutions Combined General Meeting Sensorion Hearing Loss
PRESS RELEASE published on 05/13/2025 at 07:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Sensorion publie les résultats de l’AGM avec adoption de toutes les résolutions recommandées par le CA. Détails des votes disponibles en ligne Biotechnologie Résultats Assemblée Générale Mixte Sensorion Thérapie Auditive
BRIEF published on 05/06/2025 at 07:35, 1 year 5 months ago Sensorion to Present at ASGCT Annual Meeting Gene Therapy Sensorion Hearing Loss ASGCT Meeting DFNB1A
BRIEF published on 05/06/2025 at 07:35, 1 year 5 months ago Sensorion présentera à la réunion annuelle de l'ASGCT Thérapie Génique Sensorion Perte Auditive DFNB1A Réunion De L'ASGCT
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 5 months ago Inside Information / Other news releases Sensorion announces participation at ASGCT Annual Meeting to present gene therapy research for hearing loss. Company focuses on developing innovative therapies. ASGCT 28th meeting details included Research Gene Therapy ASGCT Sensorion Hearing Loss
PRESS RELEASE published on 05/06/2025 at 07:30, 1 year 5 months ago Informations privilégiées / Autres communiqués Sensorion annonce sa participation à la conférence annuelle de l'ASGCT pour présenter ses avancées en thérapie génique et cellulaire pour la surdité. Détails des posters et programme de développement dévoilés Innovation Thérapie Génique ASGCT Sensorion Perte Auditive
Published on 10/27/2026 at 00:10, 29 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:30, 1 hour 9 minutes ago Trans Canada Gold Closes Final Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,205,737 and Prepares for Phase 2 Drilling
Published on 10/26/2026 at 23:00, 1 hour 39 minutes ago American Hotel Income Properties REIT LP to Host Third Quarter 2026 Results Conference Call on November 16, 2026
Published on 10/26/2026 at 22:00, 2 hours 39 minutes ago IBC Advanced Alloys Announces Issuance of Share-Based Compensation to Directors
Published on 10/26/2026 at 22:00, 2 hours 39 minutes ago Alset AI Announces Non-Brokered Private Placement Offering of a Minimum of $650,000 and a Maximum of $800,000
Published on 10/26/2026 at 22:23, 2 hours 16 minutes ago EQS-Adhoc: SMAG Mobile Antenna Masts AG: Changes to the Management Board
Published on 10/26/2026 at 21:57, 2 hours 41 minutes ago EQS-Adhoc: PAUL Tech AG: Noteholders’ Meeting in respect of the EUR 35 million notes resolves on extension of the term of the notes
Published on 10/26/2026 at 21:32, 3 hours 6 minutes ago UPDATE ON STRATEGIC TRANSACTION, FURTHER PORTFOLIO DISPOSAL PROCESS AND CONTINUED LENDER SUPPORT
Published on 10/26/2026 at 20:00, 4 hours 39 minutes ago EQS-Adhoc: Hypoport SE: Gross profit growth and increase in EBIT in Q1-Q3 2026
Published on 10/26/2026 at 19:10, 5 hours 29 minutes ago PolyPeptide announces results of the extraordinary general meeting of shareholders
Published on 10/26/2026 at 18:11, 6 hours 28 minutes ago Declaration of transactions on own shares from October 19, 2026 to October 25, 2026
Published on 10/26/2026 at 18:11, 6 hours 28 minutes ago Déclaration des transactions sur actions propres réalisées du 19/10/2026 au 25/10/2026
Published on 10/26/2026 at 17:45, 6 hours 54 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 10/26/2026 at 17:45, 6 hours 54 minutes ago Infotel : Déclaration des transactions sur actions propres réalisées du 19 au 23 octobre 2026 dans le cadre du programme de rachat d’actions.
